Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate Clostridium difficile Colitis while...

Area of Science:

• Microbiology
• Immunology
• Gastroenterology

Background:

• Clostridium difficile infection (CDI) is a significant global health concern.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) are linked to increased CDI risk and severity, but mechanisms remain unclear.
• NSAIDs inhibit cyclooxygenase (COX) enzymes, altering prostaglandin (PG) metabolism.

Purpose of the Study:

• To investigate the mechanisms by which NSAIDs exacerbate CDI.
• To elucidate the role of prostaglandin deregulation in NSAID-associated CDI severity.

Main Methods:

• A mouse model of antibiotic-associated CDI was used.
• Mice were treated with the NSAID indomethacin prior to infection.
• Analysis included microbiota composition, mortality, intestinal pathology, gene/protein expression, and immune cell infiltration.

Main Results:

• Indomethacin treatment prior to CDI significantly increased mortality and intestinal pathology.
• NSAID treatment led to prostaglandin deregulation and altered proinflammatory profiles.
• Perturbations in epithelial cell junctions, gut microbiota, and immune cell recruitment (neutrophils, CD4+ cells) were observed.

Conclusions:

• NSAIDs disrupt protective COX-mediated PG production during CDI.
• This disruption alters epithelial integrity and associated immune responses, worsening CDI.
• Findings suggest NSAID-induced disturbances in the gut microbiome and colonic epithelial integrity contribute to CDI severity.